Articles Published in 2011 Articles | CenterWatch News Online

Articles Published in 2011

Prev 10 11 12 13 14 15 16 17 18 19 20 Next 10

Infinity, Mundipharma extend global alliance

Tuesday, November 29, 2011 02:39 PM

Infinity Pharmaceuticals has reported that Mundipharma International has committed to providing over $50 million in funding in 2013 for the continued development of IPI-145, Infinity's potent, oral inhibitor of phosphoinositide-3-kinase (PI3K) delta and gamma, as well as development candidates arising out of Infinity's innovative discovery programs. An extension of the companies' global strategic alliance, this funding reflects the broad commercial potential of IPI-145 in both hematologic cancers and inflammatory conditions as well as the continued productivity of Infinity's discovery and development programs.

More... »

AstraZeneca commits additional $100m to MedImmune

Tuesday, November 29, 2011 02:22 PM

AstraZeneca has committed an additional $100 million to its venture capital arm, MedImmune Ventures, increasing the total capital under management to $400 million. MedImmune Ventures is an evergreen venture capital fund that focuses on equity investments in private companies in the areas of biopharmaceuticals, medical and healthcare technology.

More... »

Roche, PTC sign potential $490m licensing deal

Tuesday, November 29, 2011 01:56 PM

Roche, PTC Therapeutics, and the SMA Foundation, have signed a licensing agreement for PTC's Spinal Muscular Atrophy (SMA) program. SMA is a genetic neuromuscular disorder that causes muscle weakness.

More... »

RaySearch enters agreement with Chinese distributor

Tuesday, November 29, 2011 12:55 PM

RaySearch Laboratories has entered into an exclusive distribution agreement with the Chinese distributor Kang Li Da Trading, based in Beijing. The agreement means that Kang Li Da will be fully responsible for marketing, sales and service for RaySearch’s proprietary treatment planning system RayStation on the entire Chinese market.

More... »

Unilife inks development and supply agreement

Tuesday, November 29, 2011 12:08 PM

Unilife has signed a clinical development and supply agreement with a global pharmaceutical company for a novel device for targeted organ delivery. The proprietary Unilife device is intended to be used in a drug clinical trial that is scheduled to commence in early 2012.

More... »

GenturaDx names scientific advisory board

Tuesday, November 29, 2011 11:51 AM

GenturaDx has created its scientific advisory board with three initial members: Dr. Keith Jerome, Dr. Steven Miller, and Dr. Gregory Tsongalis. The board will provide expert perspectives across science, laboratory medicine and the commercial market related to initial test development and future applications of the company's proprietary IDbox(TM). The IDbox system is set to begin clinical trials in 2012.

More... »

FDA accepts NDA for myeloma drug

Tuesday, November 29, 2011 11:34 AM

The FDA has accepted Onyx Pharmaceuticals' New Drug Application (NDA)
submission for carfilzomib, a next generation proteasome inhibitor, for the potential treatment of patients with relapsed and refractory multiple myeloma.

More... »

University of Cambridge, Elan launch research center

Monday, November 28, 2011 03:21 PM

The University of Cambridge and Elan have launched The Cambridge-Elan Centre for Research Innovation and Drug Discovery (Cambridge-Elan Centre), which will be located at the University of Cambridge, England. The Cambridge-Elan Centre will provide an interdisciplinary environment uniquely positioned for delivering translational research focused on innovative therapies for Alzheimer's and Parkinson's diseases. This ten-year agreement paves the way for a long-term collaboration between Elan and the University of Cambridge.

More... »

Lehigh Valley Health Network selects StudyManager's Reveal software

Monday, November 28, 2011 01:48 PM

Lehigh Valley Health Network has selected StudyManager’s Reveal software to manage its clinical trials.

More... »

Roche, BGI develop advanced MHC technology

Monday, November 28, 2011 11:47 AM

Roche NimbleGen and BGI have developed a major histocompatibility complex (MHC) region capture technology based on NimbleGen SeqCap EZ Choice Library, a process for the enrichment of the MHC region. This newly developed approach allows easy capture and enrichment of these highly repetitive regions and enables the generation of deep sequencing coverage of the human MHC region. This new sample preparation approach overcomes the limitations of traditional methods of PCR and genomic enrichment used for disease and drug research.

More... »